James Antoon MD PhD MPH
Hospitalist, Pediatric Healthcare Research and Healthcare Policy
Physician
Join to View Full Profile
3601 The Vanderbilt ClinicNashville, TN 37232
Phone+1 615-322-3000
Dr. Antoon is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. James Antoon, based in Nashville, TN, is a pediatric specialist with subspecialties in pediatric hospital medicine, healthcare research, and healthcare policy. He obtained his medical degree from Tulane University School of Medicine in 2012, a Master of Public Health in Epidemiology from Vanderbilt University between 2020 and 2022, and completed a PhD in Pharmacology at Tulane University. He also pursued further studies in pharmacoepidemiology at the University of Illinois at Chicago. Dr. Antoon has extensive experience in drug safety and pharmacoepidemiology, with multiple publications in high-profile journals focusing on topics such as influenza in children, pneumonia prognosis, and pediatric urinary tract infections. Additionally, he has led clinical trials related to penicillin allergy risk stratification and delabeling.
Education & Training
University of Illinois at ChicagoPharmacoepidemiology, 2022 - 2023- Vanderbilt University School of MedicineMPH, Epidemiology, 2020 - 2022
- Tulane University School of MedicinePhD, Pharmacology, 2006 - 2012
Tulane University School of MedicineClass of 2012- Tulane UniversityMSc, Pharmacology, 2004 - 2006
Certifications & Licensure
TN State Medical License 2019 - 2025
American Board of Pediatrics Pediatrics- American Board of Pediatrics Pediatric Hospital Medicine
Clinical Trials
- Feasibility Assessment of Risk Stratification and Oral Challenge in Hospitalized Children at Low Risk for Antibiotic Allergy Start of enrollment: 2020 Sep 15
- Penicillin Allergy Risk-Stratification and Delabeling of Low-Risk Patients Start of enrollment: 2022 Dec 01
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- Factors Associated with Antiviral Drug Use Among Commercially Insured Children at High Risk for Complications of Influenza.Abdullah Abdelaziz, Jyotirmoy Sarker, Pei-Wen Lien, Derek J Williams, Carlos G Grijalva
The Journal of Pediatrics. 2025-07-01 - Antiviral Prescription in Children With Influenza in US Emergency Departments: New Vaccine Surveillance Network (NVSN), 2016-2020.Tess Stopczynski, Justin Z Amarin, James W Antoon, Olla Hamdan, Laura S Stewart
Influenza and Other Respiratory Viruses. 2025-06-01 - Concerns About Data and Analyses Used in Assessing Fluoride Exposure and Children's IQ Scores.James W Antoon, Jayanth V Kumar
JAMA Pediatrics. 2025-05-12
Press Mentions
Can Carrot Juice Give You a ‘Natural Tan’?; Lorazepam Use on ‘White Lotus’; Dangers of the Flu for Children; Plus Other News Stories with VUMC SourcesMarch 13th, 2025- As Flu Rises, Experts Warn of Neurologic Complications in ChildrenFebruary 14th, 2025
- An Intense Flu Season Is Filling Hospitals with Severely Ill PatientsFebruary 14th, 2025
- Join now to see all
Professional Memberships
- Fellow
- International Society for PharmacoepidemiologyMember
- Academic Pediatric AssociationMember
- Society for Pediatric ResearchMember
- The International Society for Influenza and other Respiratory Virus Diseases (isirv)Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
